Mirikizumab

Tax included
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis.
MedChemExpress 
HY-P99737

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
CAS
1884201-71-1